These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 31306137)
1. Highly Elevated Cerebrospinal Fluid Total Tau Level Reflects Higher Likelihood of Non-Amnestic Subtype of Alzheimer's Disease. Pillai JA; Bonner-Jackson A; Bekris LM; Safar J; Bena J; Leverenz JB J Alzheimers Dis; 2019; 70(4):1051-1058. PubMed ID: 31306137 [TBL] [Abstract][Full Text] [Related]
2. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease. Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028 [TBL] [Abstract][Full Text] [Related]
3. Visual Ratings of Medial Temporal Lobe Atrophy Correlate with CSF Tau Indices in Clinical Variants of Early-Onset Alzheimer Disease. Granadillo E; Paholpak P; Mendez MF; Teng E Dement Geriatr Cogn Disord; 2017; 44(1-2):45-54. PubMed ID: 28675901 [TBL] [Abstract][Full Text] [Related]
4. Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease. Phillips JS; Das SR; McMillan CT; Irwin DJ; Roll EE; Da Re F; Nasrallah IM; Wolk DA; Grossman M Hum Brain Mapp; 2018 Feb; 39(2):691-708. PubMed ID: 29105977 [TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias. de Souza LC; Lamari F; Belliard S; Jardel C; Houillier C; De Paz R; Dubois B; Sarazin M J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):240-6. PubMed ID: 20802215 [TBL] [Abstract][Full Text] [Related]
6. Factors that influence the levels of cerebrospinal fluid biomarkers in memory clinic patients. Knapskog AB; Eldholm RS; Braekhus A; Engedal K; Saltvedt I BMC Geriatr; 2017 Sep; 17(1):210. PubMed ID: 28893185 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants. Abu Rumeileh S; Lattanzio F; Stanzani Maserati M; Rizzi R; Capellari S; Parchi P J Alzheimers Dis; 2017; 55(4):1471-1480. PubMed ID: 27886009 [TBL] [Abstract][Full Text] [Related]
8. Increased cerebrospinal fluid tau levels in logopenic variant of Alzheimer's disease. Magnin E; Paquet C; Formaglio M; Croisile B; Chamard L; Miguet-Alfonsi C; Tio G; Dumurgier J; Roullet-Solignac I; Sauvée M; Thomas-Antérion C; Vighetto A; Hugon J; Vandel P J Alzheimers Dis; 2014; 39(3):611-6. PubMed ID: 24217280 [TBL] [Abstract][Full Text] [Related]
9. Race modifies the relationship between cognition and Alzheimer's disease cerebrospinal fluid biomarkers. Howell JC; Watts KD; Parker MW; Wu J; Kollhoff A; Wingo TS; Dorbin CD; Qiu D; Hu WT Alzheimers Res Ther; 2017 Nov; 9(1):88. PubMed ID: 29096697 [TBL] [Abstract][Full Text] [Related]
10. MRI and CSF studies in the early diagnosis of Alzheimer's disease. de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364 [TBL] [Abstract][Full Text] [Related]
11. Visual cognition in non-amnestic Alzheimer's disease: Relations to tau, amyloid, and cortical atrophy. Putcha D; Brickhouse M; Touroutoglou A; Collins JA; Quimby M; Wong B; Eldaief M; Schultz A; El Fakhri G; Johnson K; Dickerson BC; McGinnis SM Neuroimage Clin; 2019; 23():101889. PubMed ID: 31200149 [TBL] [Abstract][Full Text] [Related]